News Sentiment

LCTX sentiment intelligence

Lineage Cell Therapeutics, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 51 Balanced news tone 20 relevant articles
Exchange TLV Israel
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 363.50 Week of 19 Jun 2026
Weighted tone 51/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

83/100 classification confidence.

Company focus 20

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-8.4% over one week, +8822.4% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Lineage Cell Therapeutics Inc (LCTX) Dividends & Stock Splits: Historical Payouts and Event Timeline

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 83/100 classification
One-week reaction -8.4% Price reacting lower
Trend fit Trend active 8822.4% over four weeks
Fair value 3199.3% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 16
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 20
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingKey 5
Market source 5
Stock Titan 5
Business Wire 3
The Globe and Mail 1
GuruFocus 1

Event Lens

What the news is about

Classified themes
Market update 13
Earnings 5
Analyst action 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-20 of 20